Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanoma immunotherapy: past, present, and future.

Farid Saleh1, Waleed Renno, Ivo Klepacek

  • 1Faculty of Medicine, Health Sciences Centre, Department of Anatomy, Kuwait University. Jabriya, P.O.Box: 24923, Safat, Kuwait, Postal Code 13110, Kuwait. Fred@hsc.edu.kw

Current Pharmaceutical Design
|October 27, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypophosphite Is a Naturally Occurring Selective Inhibitor of Syntrophic Methanogenesis.

Environmental science & technology·2026
Same author

Postoperative Complications After Lumbar Spinal Surgery in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Virtual GERAS DANcing for Cognition Exercise (DANCE) for older adults at home: a randomized feasibility trial.

Pilot and feasibility studies·2026
Same author

Aggressive Prostatic Stromal Sarcoma Mimicking Benign Prostatic Enlargement in a Middle-Aged Man: A Case Report.

Clinical case reports·2026
Same author

[Involving Patient Partners: Platforms and Strategies in French-Speaking Switzerland].

Revue medicale suisse·2025
Same author

Combined Effect of Pre-Operative Antibiotics and Enema for Surgical Site Infection Prevention in Anorectal Surgery: A Retrospective Study.

Surgical infections·2025

Cancer vaccine immunotherapy offers a promising, safer alternative to traditional treatments. Recent advances in identifying tumor antigens have refined melanoma vaccines, showing potential for tumor regression and improved survival rates.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Cancer incidence is rising globally, posing a significant public health challenge.
  • Cancer vaccine immunotherapy is an emerging, safer treatment modality compared to chemotherapy and radiotherapy.
  • Advances in identifying tumor antigens have enabled the development of refined cancer vaccines.

Purpose of the Study:

  • To provide an update on melanoma vaccine immunotherapy.
  • To review different cancer antigens, with a focus on melanoma-specific antigens.
  • To summarize clinical trials and case studies of melanoma vaccination strategies.

Main Methods:

  • Review of scientific literature on cancer vaccine immunotherapy.
  • Detailed description of identified melanoma antigens.

Related Experiment Videos

  • Summary of clinical trials and case studies involving various melanoma vaccine types.

    • Main Results:

    • Melanoma vaccine immunotherapy has shown partial or complete tumor regression in some patients.
    • Disease-free survival rates have increased in certain patient groups treated with cancer vaccines.
    • Outcomes are particularly evident in patients with melanoma.

    Conclusions:

    • Melanoma vaccine immunotherapy represents a promising approach for cancer treatment.
    • Continued research into tumor antigens and vaccine development is crucial.
    • Various vaccine platforms, including cell-based, peptide, vector-based, and dendritic cell vaccines, are being investigated for melanoma.